Salute e Benessere

Novartis announces expiration of Tourmaline Bio tender offer 

Basel, October 28 2025 - Novartis today announced that its previously announced tender offer (the “offer”) by Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), to acquire all of the outstanding shares of common stock, par value $0.0001 per share (the “Shares”), of Tourmaline Bio, Inc., a Delaware corporation (“Tourmaline”), at a price of $48.00 per Share, in cash, without interest and subject to any applicable withholding,...
Nasdaq GlobeNewswire
28/10/2025

Navamedic ASA: Double digit growth in the 3rd quarter, 2025

The acquisition of the dne pharma business was completed in July, with a subsequent successful rights issue completed in October. The acquisition of the dne pharma business was completed in July, with a subsequent successful rights issue completed in October. "We are excited about the acquisition of the dne pharma business. The portfolio of products we have acquired fits well into the Navamedic setup and provides a new focus area with growth potential, Addiction, within our Rx portfolio...
PR Newswire
28/10/2025

Meiyume at Cosmopack Asia 2025: SEEDED -- Rooted in Intelligence, Connected…

At the heart of every innovation lies a seed—an idea ready to grow. SEEDED reflects how intelligence, ethical sourcing, inventive formulations, and sustainable packaging are interconnected at Meiyume, creating an ecosystem where innovation evolves into successful global products for clients and partners. At the heart of every innovation lies a seed—an idea ready to grow. SEEDED reflects how intelligence, ethical sourcing, inventive formulations, and sustainable packaging are interconnected at...
PR Newswire
28/10/2025

Novartis delivers solid sales and core operating income growth with strong…

Ad hoc announcement pursuant to Art. 53 LR Q3 net sales grew +7% (cc 1, +8% USD) and core operating income 1grew +7% (cc, +6% USD)Sales growth was driven by continued strong execution on priority brands includingKisqali(+68% cc),Kesimpta(+44% cc),Pluvicto(+45% cc) andScemblix(+95% cc)Core operating income margin 1was stable (cc) at 39.3% despite increasing generic impact Q3 operating income grew +27% (cc, +24% USD); net income rose +25% (cc, +23%…
Nasdaq GlobeNewswire
28/10/2025

Press release: Sanofi successfully prices USD 3 billion of bond issue

Sanofi successfully prices USD 3billion of bond issue Paris, France – October 28, 2025 -Sanofi announces that it has successfully priced its offering of $3 billion of notes across 5 tranches: $400 million fixed rate notes, due November 2027, bearing interest at a rate of 3.75%. $500 million floating rate notes, due November 2027, bearing interest at compounded SOFR plus 0.46%. $400 million fixed rate notes, due November 2028, bearing interest at a rate of 3.80%. $500 million...
Nasdaq GlobeNewswire
28/10/2025

Positive phase III results for Roche’s Gazyva/Gazyvaro in children and young…

Gazyva/Gazyvaro versus mycophenolate mofetil shows significantly more children and young adults achieved sustained complete remission at week 52 If approved, Gazyva/Gazyvaro could help children and young adults sustain remission, potentially with a reduced need for steroids to manage their disease 1 INShore is the first global phase III study of a targeted therapy in this chronic kidney disease commonly diagnosed in early childhoodBasel, 28 October 2025 - Roche (SIX: RO, ROG;...
Nasdaq GlobeNewswire
28/10/2025

138th Canton Fair Exhibitors Respond to Global Consumer Trends with Sustainable…

At this session, several exhibitors are introducing new eco-friendly household solutions. One exhibitor presented a biodegradable tableware collection made from agricultural byproducts such as sugarcane pulp, which naturally decomposes by more than 90% within a month. The series has earned multiple patents and international certifications for food safety. Another exhibitor focused on modular home storage systems crafted from recycled polypropylene (PP), designed with detachable components that…
PR Newswire
28/10/2025

Onward Therapeutics Exercises Exclusive Option and Signs Worldwide License…

The program, designated OT-S00X by Onward Therapeutics, is an innovative onco-metabolism project aimed at expanding therapeutic possibilities in cancer treatment. Proof-of-principle studies have demonstrated strong preclinical efficacy, and promising candidates from two distinct chemical series have already been identified, and compounds with improved physico-chemical properties will be generated through artificial intelligence approaches. The program, designated OT-S00X by Onward...
PR Newswire
28/10/2025

Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and…

Basal Cell Nevus Syndrome Market Summary Basal Cell Nevus Syndrome Market Summary Discover the basal cell nevus syndrome new treatment @New Treatments for Basal Cell Nevus Syndrome Key Factors Driving the Growth of the Basal Cell Nevus Syndrome Market Rising BCNS Prevalence and Awareness BCNS, also known as Gorlin Syndrome, is a rare genetic disorder characterized by multiple basal cell carcinomas and other abnormalities. The estimated prevalence inEuropevaries...
PR Newswire
27/10/2025

Inside information: Bioretec adjusts and restates previously reported net sales…

Following the signing of the TSB Distribution Agreement, it became evident that the sales of Bioretec's products in 2025 were not progressing in line with expectations of the TSB Distribution Agreement, and a product repurchase addendum was added on 5 May 2025 to the TSB Distribution Agreement, whereby Bioretec would repurchase from TSB such unpaid products for which TSB was unable to procure purchasers within the payment terms ("Repurchase Addendum"). Following such repurchase under…
PR Newswire
27/10/2025

Syngene International announces plans to add bioconjugation suite for end-to-end…

The OEB-5 rated suite will accelerate ADC development timelines by enabling both Monoclonal Antibodies (mAb) production and GMP bioconjugation at a single site, complementing Syngene's existing commercial capabilities in payload and linker manufacturing. Expected to be operational within this financial year, the conjugation facility will also support a range of advanced conjugates and related modalities. These services are further strengthened by collocated analytical and bioanalytical…
PR Newswire
27/10/2025

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European…

Saint-Herblain (France), October 27 , 2025 –Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at upcoming investor conferences in the United States and Europe. Valneva will host moderated “fireside chat” presentations to discuss the Company’s key value drivers and upcoming catalysts, primarily the upcoming Phase 3 trial outcomes for...
Nasdaq GlobeNewswire
27/10/2025

Global Optogenetics Equipment Market Valued at USD 400 Million in 2024…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1067180 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1067180 202 - Pages126 – Tables37 – Figures Scope Of The Report Feed Antioxidants Market Overview 1. Rising Global Adoption of Optogenetic Technologies The Optogenetics Equipment Market is witnessing widespread adoption across neuroscience and biomedical research sectors. Researchers are...
PR Newswire
27/10/2025

Tendon Repair Market to Reach $2.8 Billion by 2027 in the short term and $4.1…

Request Sample of the Report on Tendon Repair Market Forecast 2034 – https://www.alliedmarketresearch.com/request-sample/A17088 Request Sample of the Report on Tendon Repair Market Forecast 2034 –https://www.alliedmarketresearch.com/request-sample/A17088 Market Introduction The tendon repair market focuses on the development and commercialization of surgical and non-surgical treatments aimed at restoring tendon function after injury or degeneration. Tendon injuries are common...
PR Newswire
27/10/2025

Global Ovulation Test Market Driven by Rising Fertility Awareness, Technological…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=306139 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=306139 202 – Pages 126 – Tables 37 – Figures Scope Of The Report Feed Antioxidants Market Overview 1. Market Definition and ScopeThe Ovulation Test Market encompasses products designed to help women detect fertile periods by measuring hormone levels, primarily luteinizing hormone (LH), in urine...
PR Newswire
27/10/2025

Japan Anti-Aging Product Market Set to Reach USD 6.15 Billion by 2033 as Premium…

Browse in-depth TOC on "Japan Anti-Aging Products Market" 76 – Tables69 – Figures189 – Pages Browse in-depth TOC on "Japan Anti-Aging Products Market"76 – Tables 69 – Figures 189 – Pages Market Segmentation: Product Type, Age Group, Gender & Channel Within the Japanese anti-aging sector, growth dynamics are manifest across multiple segmentation axes. ByProduct Type, the market coversSkincare(including moisturizers, serums and concentrates, eye care, cleansers &...
PR Newswire
27/10/2025

The WEMP Foundation and Rafa Nadal Foundation are joining together to Support…

Dr. Adrian Cheng has invited Rafael Nadalas a co-host of The Children Ball 2025. The two began their partnership with the launch of Asia's first and only Rafa Nadal Tennis Center Hong Kong under Rafa Nadal Academy by Movistar in Hong Kong. Dr. Cheng and Mr. Nadal are deeply committed to the cause, sharing a profound belief that investing in the wellbeing of children is crucial for fostering a brighter future for society. The partnership not only highlights their shared values but also emphasizes…
PR Newswire
27/10/2025

Chromatin Bioscience Announces Collaboration with Purespring Therapeutics

"Purespring's approach to gene therapy aligns well with our mission to provide precise gene control systems that support advanced, tissue-targeted therapeutics," said Michael Roberts, CEO and Founder of Chromatin Bioscience. "We are excited to support their efforts with our platform and help unlock the full therapeutic potential of next-generation gene therapies." "Purespring's approach to gene therapy aligns well with our mission to provide precise gene control systems…
PR Newswire
27/10/2025

Protein Ingredients Market to Reach USD 125.1 Billion by 2031 Amid Rising Demand…

Market Dynamics: From Nutrition to Innovation Market Dynamics: From Nutrition to Innovation The growing global appetite for protein-driven by lifestyle shifts, fitness trends, and population growth-is propelling innovations in bothplant-basedandanimal-derivedprotein ingredients. Key growth drivers include: Download PDF Brochure:https://www.datamintelligence.com/download-sample/protein-ingredients-market Browse in-depth TOC on "Protein Ingredients Market" ...
PR Newswire
27/10/2025

/C O R R E C T I O N -- SheMed/

LONDON, Oct. 23, 2025 /PRNewswire/ -- SheMed, the female-founded health technology company changing how women access personalised healthcare, today announced it has raised $50 million at a $1bn valuation to further develop its innovative health platform and advance new breakthroughs for preemptive healthcare. LONDON , Oct. 23, 2025 /PRNewswire/ -- SheMed , the female-founded health technology company changing how women access personalised healthcare, today announced it has raised$50...
PR Newswire
27/10/2025

Queen Square Imaging Centre: New technique could improve outcomes for essential…

Now, a new technique using FAT1 imaging - a sophisticated MRI approach that fuses multiple scan types - is offering hope to patients. Now, a new technique using FAT1 imaging - a sophisticated MRI approach that fuses multiple scan types - is offering hope to patients. A study inBMJ Neurology Openstudy reports the first use of FAT1 imaging to guide focused ultrasound for essential tremor. Traditionally, clinicians have relied on generalised brain maps to estimate the location of the target...
PR Newswire
27/10/2025

Philips introduces industry-first cath lab integration that automatically…

October 27, 2025 New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchronizes CT images with C-arm movement, supporting workflow efficiency and additional anatomical insights in PCI procedures 1 San Francisco, USA and Amsterdam, The Netherlands –At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting,Royal Philips(NYSE: PHG, AEX: PHIA),...
Nasdaq GlobeNewswire
27/10/2025

Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program

"This End-of-Phase 2 meeting is a crucial milestone for our refractory gout program" says Dr. Bing Li, Shanton's CEO, "as it provides alignment with FDA on our upcoming Phase 3 pivotal program, including protocol, trial design, patient population, dose selection, proposed endpoints, and statistical analysis methods. Based on FDA's feedback we are confident to enter into a Multi-Regional Clinical Trial program in the coming months, aiming to offer a much-needed solution for…
PR Newswire
27/10/2025

Curia Invests $4 Million to Enhance Sterile API Manufacturing

The enhancements support upgrades to Valladolid’s infrastructure and technology. Curia used innovative tools to take advantage of new possibilities derived from the application of an enhanced process understanding. The bulk of the investment was dedicated to updating the site’s equipment, including the installation of new isolators, along with modernizations to HVAC, pharmaceutical panels, automation, sterilization in place and general utilities. Transitioning to a fully closed system was...
Nasdaq GlobeNewswire
27/10/2025
Altri  Comunicati